Long form Immutep interview with CEO Marc Voigt

  1. 9 Posts.
    lightbulb Created with Sketch. 2

    00:00 Introduction to Lung Cancer and Its Challenges02:32 Understanding Treatment Options for Lung Cancer05:22 The Evolution of Immunotherapy08:00 Immutep's Innovative Approach to Cancer Treatment10:39 Clinical Trials and Promising Data13:47 Collaboration with Merck and Future Prospects25:48 Clinical Trials and Efficacy Analysis28:03 Commercial Opportunities in Oncology31:15 Acquisition Trends in Biotech31:38 Advancements in Head and Neck Cancer Treatment37:32 Exploring Autoimmune Disease Treatments45:26 Financial Strategies and Investment Priorities

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $381.6M
Open High Low Value Volume
26.0¢ 27.0¢ 26.0¢ $408.4K 1.550M

Buyers (Bids)

No. Vol. Price($)
11 406961 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 56625 2
View Market Depth
Last trade - 16.10pm 12/08/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.